Cargando…
Short course of simvastatin has no effect on markers of endothelial activation in normolipidemic patients with systemic sclerosis
OBJECTIVE: Statins, a class of 3-hydroxy-3 methyl-glutaryl-coenzyme A reductase inhibitors, are widely used for the treatment of atherosclerosis. Less is known about the role of statins in the treatment of vascular complication in systemic sclerosis (SSc). We therefore performed a short-term interve...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5991246/ https://www.ncbi.nlm.nih.gov/pubmed/29557229 http://dx.doi.org/10.1177/0300060518762681 |